Relmada Therapeutics Announces Publication of Full Results from Phase I Study Showing Treatment with d-Methadone to be Safe and Well Tolerated

By WebmasterMarch 1, 2016November 1st, 2024No Comments

Relmada Therapeutics Announces Publication of Full Results from Phase I Study Showing Treatment with d-Methadone to be Safe and Well Tolerated

Previous PostMelior Pharmaceuticals Achieves Partnership Milestone with Bukwang Pharmaceutical Co.
Next PostHealthQX First To Achieve Certification With HCI3's Latest Version